Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06344065 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 3, 2024 (before its estimated May 25, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The purpose of this study is to evaluate the safety and immunogenicity of the DTaP in 3-month-old infants.
Trial Details
NCT Number NCT06344065
Lead Sponsor Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Conditions
(from sponsor)		 Healthy Volunteers
Enrollment 1,584 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov